Israel Englander Ovid Therapeutics Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Millennium Management LLC holds 78,024 shares of OVID stock, worth $101,431. This represents 0.0% of its overall portfolio holdings.

Number of Shares

78,024

Previous 145,965 46.55%

Holding current value

$101,431

Previous $445,000 86.52%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.7 - $3.34 $47,558 - $226,922	-67,941 Reduced 46.55%	78,024 $60,000
Q1 2024 May 15, 2024	BUY	$2.72 - $4.04 $397,024 - $589,698	145,965 New	145,965 $445,000
Q1 2023 May 15, 2023	BUY	$1.88 - $2.85 $246,678 - $373,954	131,212 Added 92.6%	272,916 $704,000
Q4 2022 Feb 14, 2023	SELL	$1.43 - $1.89 $126,497 - $167,189	-88,460 Reduced 38.43%	141,704 $264,000
Q3 2022 Nov 14, 2022	SELL	$1.84 - $2.26 $25,844 - $31,743	-14,046 Reduced 5.75%	230,164 $424,000
Q2 2022 Aug 15, 2022	SELL	$1.69 - $3.31 $351,276 - $688,003	-207,856 Reduced 45.98%	244,210 $525,000
Q1 2022 May 16, 2022	BUY	$2.65 - $3.49 $175,692 - $231,383	66,299 Added 17.19%	452,066 $1.42 Million
Q4 2021 Feb 14, 2022	SELL	$3.13 - $3.73 $84,898 - $101,172	-27,124 Reduced 6.57%	385,767 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $1.17 Million - $1.43 Million	-352,759 Reduced 46.07%	412,891 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $2.53 Million - $3.44 Million	765,650 New	765,650 $2.99 Million
Q1 2021 May 17, 2021	SELL	$2.42 - $4.47 $614,791 - $1.14 Million	-254,046 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.28 - $6.84 $496,444 - $1.49 Million	217,739 Added 599.72%	254,046 $587,000
Q3 2020 Nov 16, 2020	SELL	$5.39 - $8.24 $2.62 Million - $4.01 Million	-486,289 Reduced 93.05%	36,307 $208,000
Q2 2020 Aug 14, 2020	BUY	$2.67 - $7.91 $330,113 - $977,976	123,638 Added 30.99%	522,596 $3.85 Million
Q1 2020 May 14, 2020	BUY	$2.03 - $4.35 $160,615 - $344,176	79,121 Added 24.74%	398,958 $1.19 Million
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $455,262 - $1.11 Million	218,876 Added 216.79%	319,837 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$1.76 - $3.51 $434,744 - $867,019	-247,014 Reduced 70.99%	100,961 $327,000
Q2 2019 Aug 15, 2019	SELL	$1.59 - $2.14 $2.18 Million - $2.93 Million	-1,370,058 Reduced 79.75%	347,975 $644,000
Q2 2019 Aug 14, 2019	BUY	$1.59 - $2.14 $2.73 Million - $3.68 Million	1,718,033 New	1,718,033 $47.7 Million
Q1 2019 May 14, 2019	SELL	$1.77 - $3.56 $39,446 - $79,338	-22,286 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$2.42 - $6.6 $166,851 - $455,050	-68,947 Reduced 75.57%	22,286 $54,000
Q3 2018 Nov 14, 2018	BUY	$5.6 - $11.0 $426,456 - $837,683	76,153 Added 504.99%	91,233 $517,000
Q2 2018 Aug 14, 2018	SELL	$6.16 - $10.14 $272,666 - $448,836	-44,264 Reduced 74.59%	15,080 $118,000
Q1 2018 May 15, 2018	BUY	$6.53 - $9.82 $387,516 - $582,758	59,344 New	59,344 $420,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39.4M

Call Options Held

10.3K

Put Options Held

200

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $91.5M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account